Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kamilia Daldoul"'
Autor:
Alison Hirukawa, Salendra Singh, Jarey Wang, Jonathan P. Rennhack, Matthew Swiatnicki, Virginie Sanguin-Gendreau, Dongmei Zuo, Kamilia Daldoul, Cynthia Lavoie, Morag Park, Eran R. Andrechek, Thomas F. Westbrook, Lyndsay N. Harris, Vinay Varadan, Harvey W. Smith, William J. Muller
Publikováno v:
Cell Reports, Vol 29, Iss 2, Pp 249-257.e8 (2019)
Summary: Monoclonal antibodies (mAbs) targeting the oncogenic receptor tyrosine kinase ERBB2/HER2, such as Trastuzumab, are the standard of care therapy for breast cancers driven by ERBB2 overexpression and activation. However, a substantial proporti
Externí odkaz:
https://doaj.org/article/d72321d9dd27483ea95dfcd6db827f5b
Autor:
William J. Muller, Morag Park, Jonathan P. Rennhack, Dongmei Zuo, Harvey W. Smith, Jarey Wang, Alison Hirukawa, Thomas F. Westbrook, Kamilia Daldoul, Matthew R. Swiatnicki, Salendra Singh, Lyndsay Harris, Vinay Varadan, Cynthia Lavoie, Virginie Sanguin-Gendreau, Eran R. Andrechek
Publikováno v:
Cell Reports, Vol 29, Iss 2, Pp 249-257.e8 (2019)
Summary: Monoclonal antibodies (mAbs) targeting the oncogenic receptor tyrosine kinase ERBB2/HER2, such as Trastuzumab, are the standard of care therapy for breast cancers driven by ERBB2 overexpression and activation. However, a substantial proporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c5efebdf5885edbf16311093c0323d
http://www.sciencedirect.com/science/article/pii/S2211124719311672
http://www.sciencedirect.com/science/article/pii/S2211124719311672